Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z102 long-term safety trial in rheumatoid arthritis
2011-002392-41Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prednisolone + dipyridamole in rheumatoid arthritis (RA) (3 arms), sponsored by CombinatoRx. Primary endpoint: Primary safety endpoint. Started Dec 2011; status: completed.
02
Drugs
prednisolone + dipyridamole
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-002392-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002392-41.